Status:
UNKNOWN
Hyperbaric Oxygen Treatment in Autism Spectrum Disorders
Lead Sponsor:
General Administration of Military Health, Tunisia
Collaborating Sponsors:
Military Hospital of Tunis
Conditions:
Child Autism
Eligibility:
All Genders
4-14 years
Phase:
NA
Brief Summary
Hyperbaric oxygen therapy (HBOT) is part of a multidisciplinary therapeutic management of infant autism including psychotherapy, drug treatment and other therapeutics (speech therapy, occupational the...
Detailed Description
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by difficulties in verbal and non-verbal communication and social interactions. People with ASD often exhibit difficult be...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All children aged 4 to 14 years who were followed in the child psychiatry unit during the study period and who were identified as having a diagnosis of ASD. This diagnosis was made by child psychiatrists experienced in autism using the DSM-5 criteria and the ADI and the Childhood Autism Rating Scale (CARS)
- Criteria for non-inclusion :
- Children with hearing or visual impairments
- Children with unbalanced epilepsy
- Children with a contraindication to HBOT
- Dysfunction of the immune system
- Exclusion criteria
- Child that havent completed entire protocol
Exclusion
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04472780
Start Date
June 1 2019
End Date
October 1 2021
Last Update
September 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HBOT Department Military Hospital
Tunis, Montfleury, Tunisia, 1008